Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Coherus BioSciences, Inc. (CHRS)

« Back to company index

CHRS Chatter Timeline

Stock Ticker for CHRS

Most Active Tweeters for CHRS

UserTweets
@Tickeron 14
@TheMarketsDaily 5
@1MinuteStock 5
@AG1L1S 5
@dakotafinancial 4

Recent Tweets for CHRS

scrooge_fs @scrooge_fs
An aquisition for stock $CHRS has been executed #pennyStocks #stocks #MergerAgreement #Trade #StockTrading
November 19th 2019, 7:11pm
Tickeron @Tickeron
$CHRS's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/2XC6pQc8nu
November 19th 2019, 6:11pm
stockmktgenius @stockmktgenius
$CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 19.61 Liq: $18M https://t.co/PM5S1zW6Uw
November 19th 2019, 6:11pm
AG1L1S @AG1L1S
$CHRS opportunity ~17.5$
November 19th 2019, 9:11am
bbnsnews @bbnsnews
Coherus Biosciences Inc $CHRS COO Sells $48,150.00 in Stock https://t.co/dmDFVPZFsN
November 19th 2019, 5:11am
sahajpancholia @sahajpancholia
RT @larrywabrams: $CHRS biosimilar to Humira now scheduled to be the EIGHT biosimilar launched in 2023. Maybe CHRS can get 3% in 2024 -- $4…
November 18th 2019, 10:11pm
AmericanBanking @AmericanBanking
Coherus Biosciences Inc $CHRS COO Sells $48,150.00 in Stock https://t.co/3tqxw6Yi3X #stocks
November 18th 2019, 6:11pm
dakotafinancial @dakotafinancial
Coherus Biosciences Inc $CHRS COO Sells $48,150.00 in Stock https://t.co/xZBN9gekXU
November 18th 2019, 6:11pm
Tickeron @Tickeron
$CHRS enters an Uptrend because Momentum Indicator exceeded the 0 level on November 7, 2019. View odds for this and… https://t.co/iIFnhLWMmD
November 18th 2019, 5:11pm
ConsumerFeed @ConsumerFeed
Coherus Biosciences COO Vincent Anicetti Sells $48,150.00 in $CHRS https://t.co/7fSBSNam9v
November 18th 2019, 5:11pm
larrywabrams @larrywabrams
$CHRS biosimilar to Humira now scheduled to be the EIGHT biosimilar launched in 2023. Maybe CHRS can get 3% in 2024… https://t.co/PZijSwwYse
November 18th 2019, 3:11pm
SwingTradeBot @SwingTradeBot
Rose Above 50 DMA today: $CHRS $PBFS ... https://t.co/qwiJH6vr1O
November 18th 2019, 2:11pm
EnterpriseLeade @EnterpriseLeade
Short Interest in Coherus Biosciences Inc $CHRS Expands By 5.5% https://t.co/83NX2Usqxw
November 18th 2019, 10:11am
TranscriptDaily @TranscriptDaily
Short Interest in Coherus Biosciences Inc $CHRS Expands By 5.5% https://t.co/1MMPDCVNaY
November 18th 2019, 10:11am
Tickeron @Tickeron
$CHRS enters an Uptrend because Momentum Indicator exceeded the 0 level on November 7, 2019. View odds for this and… https://t.co/9a4c7AT2yE
November 17th 2019, 5:11pm
1MinuteStock @1MinuteStock
Wondering about risks of $CHRS? The 21-day volatility is 19.71% https://t.co/KctqISSBuC
November 16th 2019, 9:11pm
Tickeron @Tickeron
$CHRS enters an Uptrend as Momentum Indicator exceeded the 0 level on November 7, 2019. View odds for this and othe… https://t.co/HRqtdPaisY
November 16th 2019, 5:11pm
AmericanBanking @AmericanBanking
Coherus Biosciences Inc $CHRS Short Interest Up 5.5% in October https://t.co/NByWmVTBmQ #stocks
November 16th 2019, 4:11pm
TheMarketsDaily @TheMarketsDaily
Coherus Biosciences Inc $CHRS Short Interest Up 5.5% in October https://t.co/zLhvL4Tu1r
November 16th 2019, 4:11pm
stocknewstimes @stocknewstimes
Coherus Biosciences Inc $CHRS Short Interest Up 5.5% in October https://t.co/kgmkfvpY7C
November 16th 2019, 4:11pm
Tickeron @Tickeron
$CHRS's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/LQ614XRppx
November 15th 2019, 6:11pm
larrywabrams @larrywabrams
@StanMehr $CHRS CEO never talks much about distribution of it’s exit 3Q19 share of 20% between 340B, Part B, and co… https://t.co/aDuAUy4zYZ
November 15th 2019, 11:11am
larrywabrams @larrywabrams
$CHRS will have a new #biosimilar competition from $NVS Sandoz. Will have to fight very hard to reach and maintain… https://t.co/xdqZ2llZIQ
November 15th 2019, 10:11am
tradersreport @tradersreport
RT @Tickeron: $CHRS in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/N4CKAUjEYo #Coheru…
November 14th 2019, 6:11pm
Tickeron @Tickeron
$CHRS in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/uv6hX42Lzj
November 14th 2019, 6:11pm
StockflareUS @StockflareUS
$CHRS: Coherus Biosciences Inc's forecast earnings moved 14.5% over the last week, but the price is 1.1%. It's PE r… https://t.co/pRVZen8iB2
November 14th 2019, 4:11am
Tickeron @Tickeron
$CHRS in Uptrend: Stochastic indicator remains in overbought zone for 1 day. View odds for this and other indicator… https://t.co/VkkWPy9iJo
November 13th 2019, 5:11pm
SwingTradeBot @SwingTradeBot
Rose Above 50 DMA today: $CHRS $BCTF ... https://t.co/qwiJH6vr1O
November 13th 2019, 3:11pm
BlueBioNow @BlueBioNow
$CHRS definitely going to finish over $20.96 3.36 % change recently https://t.co/6Uy5xvxSVH
November 13th 2019, 2:11pm
Gambiste1 @Gambiste1
RT @kshahi: $CHRS upcoming catalyst by year end (filing Lucentis biosimilar ) should get a nice a sp boost.
November 13th 2019, 1:11pm
kshahi @kshahi
$CHRS upcoming catalyst by year end (filing Lucentis biosimilar ) should get a nice a sp boost.
November 13th 2019, 10:11am
SwingTradeBot @SwingTradeBot
50 DMA Resistance today: $PTE $CHRS ... https://t.co/mnYaiRq1wk
November 13th 2019, 10:11am
1stOncology @1stOncology
#CoherusBioSciences Management to Present at Two Upcoming Investor #HealthcareConferences $CHRS https://t.co/hUPzWU9AzY
November 13th 2019, 7:11am
BlueBioNow @BlueBioNow
$CHRS exactly don't sell -2.66 % change recently https://t.co/6Uy5xvxSVH
November 13th 2019, 1:11am
Tickeron @Tickeron
$CHRS's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/dnwuuDTBro
November 12th 2019, 5:11pm
newsfilterio @newsfilterio
[Amend] Statement of acquisition of beneficial ownership by individuals filed with the SEC 4 days ago $CHRS https://t.co/MH1xtvzAAI
November 12th 2019, 1:11pm
AmericanBanking @AmericanBanking
Analysts’ Recent Ratings Changes for Coherus Biosciences $CHRS https://t.co/hfJWl0ei4W #stocks
November 12th 2019, 1:11pm
dakotafinancial @dakotafinancial
Analysts’ Recent Ratings Changes for Coherus Biosciences $CHRS https://t.co/Cv7LsWP5tt
November 12th 2019, 12:11pm
otcdynamics @otcdynamics
$CHRS Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences https://t.co/GklGwsWCdP
November 12th 2019, 9:11am
newsfilterio @newsfilterio
Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences $CHRS https://t.co/cx9SKKqldZ
November 12th 2019, 9:11am
dispatchtribune @dispatchtribune
Coherus Biosciences $CHRS Earns Buy Rating from Credit Suisse Group https://t.co/zu3eKiWxZn
November 12th 2019, 1:11am
OlympiaReport @OlympiaReport
Coherus Biosciences $CHRS Earns Buy Rating from Credit Suisse Group https://t.co/aCHLxiCim3
November 12th 2019, 1:11am
dailypoliticaln @dailypoliticaln
Credit Suisse Group Reaffirms “Buy” Rating for Coherus Biosciences $CHRS https://t.co/Ihq5KFb0jS
November 11th 2019, 9:11pm
Tickeron @Tickeron
$CHRS's 10-day Moving Average crossed below its 50-day Moving Average on October 9, 2019. View odds for this and ot… https://t.co/9ESmyDWCJ1
November 11th 2019, 5:11pm
ThisLincolnian @ThisLincolnian
Coherus Biosciences $CHRS Upgraded to C- by TheStreet https://t.co/89MZdPuTPx
November 11th 2019, 3:11am
WeekHerald @WeekHerald
Coherus Biosciences $CHRS Upgraded to C- by TheStreet https://t.co/5B7JYU342D
November 11th 2019, 3:11am
EnterpriseLeade @EnterpriseLeade
Brokerages Anticipate Coherus Biosciences Inc $CHRS to Announce $0.58 EPS https://t.co/oLpe2yR8tZ
November 10th 2019, 9:11pm
OlympiaReport @OlympiaReport
Coherus Biosciences Inc $CHRS Expected to Announce Quarterly Sales of $117.04 Million https://t.co/56zVdkemiV
November 10th 2019, 9:11pm
TranscriptDaily @TranscriptDaily
Analysts Expect Coherus Biosciences Inc $CHRS Will Post Earnings of $0.58 Per Share https://t.co/7VWNfIgj1I
November 10th 2019, 9:11pm
dispatchtribune @dispatchtribune
Brokerages Anticipate Coherus Biosciences Inc $CHRS Will Announce Quarterly Sales of $117.04 Million https://t.co/XTiOkPRe70
November 10th 2019, 9:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.